FIELD: biotechnologies.
SUBSTANCE: invention refers to bicyclic heterocycles of formula I and formula II , in which radicals and symbols have values specified in the formula of the invention. These compounds have inhibiting activity in relation to MEK kinase. The invention also refers to a pharmaceutical composition for treatment of hyperproliferation disease or inflammatory disease, to a method for inhibition of abnormal growth of cells or treatment of hyperproliferation disorders and to a treatment method of inflammatory diseases of a mammal. Besides, the invention refers to use of a pharmaceutical composition for preparation of a medicinal agent for treatment of the above diseases of a mammal.
EFFECT: improving compound application efficiency.
19 cl, 29 ex
Title | Year | Author | Number |
---|---|---|---|
8-ANILINOIMIDAZOPYRIDINES AND METHODS FOR USE THEREOF | 2008 |
|
RU2498985C2 |
AZABENZOFURANYL COMPOUNDS AND METHODS OF USE | 2007 |
|
RU2448111C2 |
ISOINDOLONES AND METHODS FOR USING THEM | 2009 |
|
RU2495028C2 |
5-ANILINOIMIDAZOPYRIDINES AND METHODS FOR USING THEM | 2008 |
|
RU2441004C1 |
AZABENZOTHIOPHENYL COMPOUNDS AND METHODS OF USE | 2007 |
|
RU2444524C2 |
AZAINDOLIZINES AND METHODS FOR PREPARING THEM | 2008 |
|
RU2483069C2 |
SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS KINASE 1β-ADRENERGIC RECEPTOR INHIBITORS | 2006 |
|
RU2415855C2 |
DIAZACARBAZOLES AND METHODS OF APPLICATION | 2009 |
|
RU2515972C2 |
MINERALOCORTICOID RECEPTOR ANTAGONISTS | 2012 |
|
RU2598842C2 |
Authors
Dates
2014-03-10—Published
2009-07-01—Filed